Micro-Tech (Nanjing) Co., Ltd.
688029.SS
Get informed when a big investor buys or sells
+ FollowMarket Cap$15.54B
Close$
$105.52
28.7% upside
Current Fair Value
28.7% upsideUndervalued by 28.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $15.54 Billion |
|---|---|
| Enterprise Value | $14.57 Billion |
| Dividend Yield | $1.50 (1.80%) |
| Earnings per Share | $3.05 |
| Beta | 0.27 |
| Outstanding Shares | 186,606,016 |
Return
| Return on Equity | 12.18% |
|---|---|
| Return on Assets | 9.37% |
| Return on Invested Capital | 13.79% |
Valuation & Multiples
| P/E Ratio | 30.51 |
|---|---|
| PEG | -135.82 |
| Price to Sales | 4.82 |
| Price to Book Ratio | 3.56 |
| Enterprise Value to Revenue | 4.35 |
| Enterprise Value to EBIT | 23.45 |
| Enterprise Value to Net Income | 28 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.06 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 27, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$874.00 M
Average shareholder expectationNext Earnings Call
Expected Date
October 30, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$901.68 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Micro-Tech (Nanjing) Co., Ltd.
2,369 employees
CEO: Derong Leng Micro-Tech (Nanjing) Co., Ltd. is a key manufacturer and global supplier of non-vascular stents and disposable biopsy forceps. The company's primary markets span China, Europe, North America, and Oceania. Its extensive product portfolio ...